TRIFLUOPERAZINE 2MG TABLETS

Approval Id: 09e59af34fc1decf
Drug Approval Canada Name: TRIFLUOPERAZINE 2MG TABLETS
Product Name: TRIFLUOPERAZINE 2MG TABLETS
Status: Cancelled Pre Market
Status Date: 2021-04-09
Din: 02232690
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.24
Atc Original: N05AB06 TRIFLUOPERAZINE
Atc Name: n 05 ab 06
Aig Number: 0131362003
Company Name: Laboratoires Confab Inc
Company Address: 4355 Boul. Sir Wilfrid Laurier, St-Hubert, Quebec, Canada, J3Y 3X3
Company Detail Path: /organization/laboratoires-confab-inc

TRIFLUOPERAZINE (TRIFLUOPERAZINE HYDROCHLORIDE)

2 MG / TAB

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

09e59af34fc1decf

Type

Standard